当前位置:
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Antibacterial agents: New routes to tuberculosis treatment
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-08-11 , DOI: 10.1038/nrd.2017.156 Sarah Crunkhorn
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-08-11 , DOI: 10.1038/nrd.2017.156 Sarah Crunkhorn
Treatment of drug-resistant strains of Mycobacterium tuberculosis is lengthy, involving the use of costly and less effective second-line drugs that exhibit substantial side effects. Two new papers now report the identification of novel agents that inhibit previously untargeted essential M. tuberculosis enzymes and
中文翻译:
抗菌剂:结核病治疗的新途径
结核分枝杆菌耐药菌株的治疗是漫长的,需要使用昂贵且效果较差的二线药物,这些药物表现出明显的副作用。现在有两篇新论文报道了鉴定抑制先前未靶向的必需结核分枝杆菌酶和
更新日期:2017-09-04
中文翻译:
抗菌剂:结核病治疗的新途径
结核分枝杆菌耐药菌株的治疗是漫长的,需要使用昂贵且效果较差的二线药物,这些药物表现出明显的副作用。现在有两篇新论文报道了鉴定抑制先前未靶向的必需结核分枝杆菌酶和